PATENT CLAIM ANALYSIS

Application Number: 16042475
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "464000"]

Abstract:
The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of autism spectrum disorders (ASD).

Claim (Index 2):
The method of  claim 1 , wherein the compound of formula (I) is represented by the following formula (II): in which n, A 1 , A 2 , A 3  and R 1  are as defined in  claim 1 .

Metadata:
- Claim Count in Document: 11.0
- Percentile: 95.0
- Lexical Diversity: 1.19355
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15004218', '15869672', '15038011', '13699087', '15687111']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7324351926852142
- 35 USC 102 Novelty (BERT): 0.5189320571108393
- Combined Prediction Score: 0.7110848791277767
- Mean Citation Score: 212.190992
- Max Citation Score: 225.72235
- Similarity Product: 130.6236417271048

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test